(¿Â¶óÀÎ) Á¦ 1ȸ ½ÉÀμº ¼îÅ© ¿¬±¸È¸ ½ÉÆ÷Áö¿ò : 2021-05-29±³À°ÀÏÀÚ : 2021-05-29
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) Á¦ 1ȸ ½ÉÀμº ¼îÅ© ¿¬±¸È¸ ½ÉÆ÷Áö¿òÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½ÉÀμº¼îÅ©¿¬±¸È¸
´ã´çÀÚ : ±èÀÌÇö
¿¬¶ôó : 02-3410-1768
À̸ÞÀÏ :
kcswg2021@gmail.com ±³À°Á¾·ù : ³»°ú, ÈäºÎ¿Ü°ú
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 5ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-29 ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 09:05~09:15 Case : Interesting diagnostic case related to cardiogenic shock À̽ÂÁØ(¼¼ºê¶õ½ºº´¿ø)
Åä·Ð 05-29 ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 09:15~09:25 Discussion ´Ù°»ç(´Ù¼Ò¼Ó)
±³À°½Ã°£ 05-29 ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 09:25~09:40 Clinical role of lung ultrasound for patient with shock ±è¹Î¼®(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 05-29 ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 09:40~09:55 Hemodynamic monitoring for patients with cardiogenic chock ±èÀÎö(°è¸í´ëº´¿ø)
±³À°½Ã°£ 05-29 ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 09:55~10:10 Learn new definition of CS SCAI, algorithm of NCSI ÃÖ±âÈ«(»ï¼º¼¿ïº´¿ø)
Åä·Ð 05-29 ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:10~10:30 Discussion ´Ù°»ç(´Ù¼Ò¼Ó)
ÈÞ½Ä 05-29 ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:30~10:40 ÈÞ½Ä ()
±³À°½Ã°£ 05-29 ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:40~10:50 Case : Vasopressor & inotropics related informative case in cardiogenic shock À̽ÂÇå(Àü³²´ëº´¿ø)
Åä·Ð 05-29 ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:50~11:00 Discussion ´Ù°»ç(´Ù¼Ò¼Ó)
±³À°½Ã°£ 05-29 ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 11:00~11:15 Fluid & nutritional support for patients with cardiogenic shock ±è°æÈñ(ÀÎõ¼¼Á¾º´¿ø)
±³À°½Ã°£ 05-29 ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 11:15~11:30 Vasopressor & Inotropes for the treatment in cardiogenic shock ¾Èö¹Î(¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 05-29 ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 11:30~11:45 Characteristics of cardiogenic shock center and referring of critical patients. Á¶¾çÇö(»ï¼º¼¿ïº´¿ø)
Åä·Ð 05-29 ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 11:45~12:05 Discussion ´Ù°»ç(´Ù¼Ò¼Ó)
ÈÞ½Ä 05-29 ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 12:35~13:00 ÈÞ½Ä ()
±³À°½Ã°£ 05-29 ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 13:00~13:10 Case : Complicated ECMO case ¹ÚÀÍÇö(»ï¼ºÃ¢¿øº´¿ø)
Åä·Ð 05-29 ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 13:10~13:20 Discussion ´Ù°»ç(´Ù¼Ò¼Ó)
±³À°½Ã°£ 05-29 ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 13:20~13:35 Indication & weaning of VA ECMO ¾çÁ¤ÈÆ(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 05-29 ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 13:35~13:50 Optimal timing for conversion of peripheral ECMO to central ECMO: optimization vs bleeding Á¤Àμ®(Àü³²´ëº´¿ø)
±³À°½Ã°£ 05-29 ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 13:50~14:05 Non-cardiac organ damage: neurologic complications À¯Á¤¾Ï(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 05-29 ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 14:05~14:20 Non-cardiac organ damage: renal complications ÀÓ¼ºÀ±(ºÐ´ç¼¿ï´ëº´¿ø)
Åä·Ð 05-29 ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 14:20~14:40 Discussion ´Ù°»ç(´Ù¼Ò¼Ó)
ÈÞ½Ä 05-29 ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 14:40~14:50 ÈÞ½Ä ()
±³À°½Ã°£ 05-29 ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 14:50~15:05 Management of respiratory failure in patients with cardiogenic shock È«»ó¹ü(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 05-29 ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 15:05~15:20 Mechanical complications in patients with myocardial infarction ±è¹Îö(Àü³²´ëº´¿ø)
±³À°½Ã°£ 05-29 ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 15:20~15:35 Management of postcardiotomy cardiogenic shock ¼Û½Âȯ(ºÎ»ê´ëº´¿ø)
±³À°½Ã°£ 05-29 ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 15:35~15:50 Management in patients with LVAD & Heart transplantation À±¿µ³²(¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 05-29 ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 15:50~16:05 E-CPR : What Á¤Àç½Â(°í´ë¾È¾Ïº´¿ø)
Åä·Ð 05-29 ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 16:05~16:25 Discussion ´Ù°»ç(´Ù¼Ò¼Ó)